MET Financial Statements & Analysis
Complete financial statements for MET including income statement, balance sheet, and cash flow statement. Analyze MET's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
10.2% ↑
Net Income
-23.7% ↓
Gross Margin
33.8% ↑
Operating Margin
-24.8% ↓
Balance Sheet
Current Ratio
17.3% ↑
Debt to Equity
4.2% ↓
Asset Turnover
0.2% ↑
Cash Flow
Operating Cash Flow
19.8% ↑
Net Cash Flow
444.0% ↑
Free Cash Flow
19.8% ↑
Cash Flow to Debt
11.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 69.94B | 77.08B | 10.2% | |
| Gross Profit | 19.00B | 28.02B | 47.5% | |
| Operating Income | 5.62B | 4.66B | 17.1% | |
| Net Income | 4.43B | 3.38B | 23.7% | |
| EPS | 5.98 | 4.80 | 19.7% | |
| EBITDA | 7.37B | 6.47B | 12.2% | |
| Gross Margin | 27.17% | 36.36% | 33.8% | |
| Operating Margin | 8.04% | 6.05% | 24.8% | |
| Net Income Margin | 6.33% | 4.38% | 30.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 77.08B | 69.94B | 67.71B | — | — |
| Gross Profit | 28.02B | 19.00B | 17.29B | — | — |
| Operating Income | 4.66B | 5.62B | 2.16B | — | — |
| Net Income | 3.38B | 4.43B | 1.58B | — | — |
| EPS | 4.80 | 5.98 | 1.82 | — | — |
| EBITDA | 6.47B | 7.37B | 3.92B | — | — |
| Gross Margin | 36.36% | 27.17% | 25.53% | — | — |
| Operating Margin | 6.05% | 8.04% | 3.19% | — | — |
| Net Income Margin | 4.38% | 6.33% | 2.33% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into MET's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics